Viracta Therapeutics, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Viracta Therapeutics, a clinical-stage oncology company, released its 2023 annual report, highlighting progress in clinical trials for its lead drug candidate, Nana-val, while also noting financial challenges.